New Weekly DPP-4 Inhibitor Effective in Diabetics in Japan New Weekly DPP-4 Inhibitor Effective in Diabetics in Japan

In a phase 3 study in Japanese type 2 diabetes patients, the novel once-weekly DPP-4 inhibitor omarigliptin was as effective as daily sitagliptin for glycemic control and was generally well tolerated. Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news